Managed Care Hemo

National Hemophilia Foundation

Website provided by National Hemophilia Foundation and its education partners

Tag

Hemophilia Education for Managed Care and Payer Professionals

CME/CE


ManagedCareHemo.com Presents Cases in Cost Optimization and Care Coordination for Managed Care and Specialty Pharmacy – Certified for Nurses, Pharmacists, and Physicians

Up to  1.0 credit hour available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

  • Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
  • Review alignment of recently approved therapies in the current hemophilia treatment algorithm
  • Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
  • Apply processes for managed care and specialty pharmacy professionals to improve communication and collaboration with HTCs

Expert Faculty

James T. Kenney, RPh, MBA
Founder and President
JT Kenney, LLC


Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center

John Fox, MD, MHA
Chief Boundary Spanner
Foxworthy Healthcare Consulting, LLC

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/costoptimization/

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Medical Education Resources.
 
This activity is supported by independent educational grants from BioMarin, CSL Behring, Sanofi Genzyme, Takeda, and uniQure, Inc.


 

ManagedCareHemo.com Presents a Clinical Primer: Cost Optimization and Care Coordination for Managed Care and Specialty Pharmacy – Certified for Nurses, Pharmacists, and Physicians

Up to  1.0 credit hour available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

  • Describe recent insights into the safety, efficacy, and unique attributes of recently approved and emerging hemophilia treatment options.
  • Review alignment of recently approved therapies in the current hemophilia treatment algorithm.
  • Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences.
  • Apply processes for managed care and specialty pharmacy professionals to improve communication and collaboration with HTCs

Expert Faculty

James T. Kenney, RPh, MBA
Founder and President
JT Kenney, LLC


Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center

John Fox, MD, MHA
Chief Boundary Spanner
Foxworthy Healthcare Consulting, LLC

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/clinicalprimer/

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Medical Education Resources.
 
This activity is supported by independent educational grants from BioMarin, CSL Behring, Sanofi Genzyme, Takeda, and uniQure, Inc.